Resurrecting MeCell Maps with Claude Code
One evening, 44 commits, and a decade-old project lives again
Maximilian Schons
Ideas to Absorb, (Verify), Adopt, Adapt.
Latest posts
Comparing AI Labs and Pharmaceutical Companies
What the AI industry can learn from pharma: safety budgets, scientific rigor, and ecosystem checks and balances.
My human cell map illustration MeCell now in the public domain
My learning resource for students of the human cell available now for free in English, Spanish, Chinese and German.
The 100h clinical trial
A blueprint for 100-hour pharmaceutical response teams to deploy vaccines at outbreak sites. Speed is the decisive factor.
Alvea: Case Study of the fastest biotech to go to in-human trials (5/6 Drug Development Series)
Core culture principles and activities that we believe enabled the team to achieve exceptional results.
Conclusions Drug Development Explainer Series (6/6)
Conclusions from the 4 core articles in this series on history, stakeholders, quality, and operations.
Origins of the Drug Regulation Industry (3/6 Drug Development Series)
One begins to wonder – why does drug development necessitate all this rigour, time, and money? Understanding drug development's history might offer context.
Recommended Literature and Courses (4/6 Drug Development Series)
The best additional literature and course resources on drug development we are aware of at this point.
The Blueprint of Drug Development (2/6 Drug Development Explainer Series)
The phases of drug development and how Good Practices (GxP) ensure pharmaceutical quality, safety, and efficacy.
Drug Development Explainer Series
A concise introduction to drug development and its regulation. Get up to speed in ~1h on how pharma works.
Stakeholders in Drug Development (1/6 Drug Development Explainer Series)
An overview of drug development stakeholders: regulators, sponsors, CROs, trial sites, and how they work together.